Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01065805 : A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
PhasePhase 1/Phase 2
AgesMin: 16 Years Max: N/A
Eligibility
Inclusion Criteria:

- Male or female greater than or equal to 16 years of age. If female of child-bearing
potential and outside of the window of 10 days since the first day of last menstrual
period, a negative pregnancy test is required.

- Patients with known primary or suspected primary, recurrent or metastatic carcinoma
of the lung, breast, renal cell, pancreas or brain (including GGM,
oligodendrogliomas, and brain metastases from any primary tumour) and with
gastrointestinal malignancies, neuroendocrine tumours (including carcinoid and islet
cell malignancies, or lymphoma, with at least one lesion >1 cm in diameter.

- Biochemical parameters as measured are required to be within 5 times the normal
limits for age.

- Able and willing to follow instruction and comply with the protocol

- Provide written informed consent prior to participation in the study

- Karnofsky Performance Scale Score 50-100

Exclusion Criteria:

- Previous removal of entire tumour

- Biochemical parameters as measured outside 5 times the normal limits for age

- Unable or unwilling to follow instructions and comply with the protocol

- Unable or unwilling to provide written informed consent prior to participation in the
study

- Karnofsky Performance Scale Score < 50

- Nursing or pregnant females

- Age less than 16 years
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01065805      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740